Dr. Christopher Rose is currently Professor in the Department of Medicine at the Université de Montréal. He is director of the Hepato-Neuro laboratory which is located at University Hospital Research Center (CRCHUM). Dr. Rose received his PhD (Neuroscience/Biomedical Sciences) from the Université de Montréal in 2000. He continued his research interests in Europe by pursuing post-doctoral studies in Germany (Prof. Kettenmann, Berlin), Spain (Prof. Felipo, Valencia and Prof. Cordoba, Barcelona) and Norway (Dr. Ytrebo, Tromso). Dr. Rose's research interests lie within the area of liver disease and hepatic encephalopathy (HE), a field in which he has been researching for over 30 years. HE, a major neuropsychiatric complication of liver disease, touches close to 80% of patients with cirrhosis affecting their quality of life and resulting in significant socioeconomic burden, morbidity and mortality both pre and post-liver transplant. Translational research is the primary objective of Dr. Rose's laboratory and, therefore, his research program is based on a bench-to-bedside concept. Dr. Rose has a vested interest in deciphering the role of ammonia and the pathophysiological pathways involved in the development of cerebral complications associated with liver disease which ultimately will lead to novel therapeutic approaches, improving the management of patients with liver disease as well as neurological outcome post-liver transplantation. Dr. Rose is an expert and internationally recognized researcher in the field of hepatic encephalopathy. His research implicates both cellular models, animal models and patients. Dr. Rose has the ability to mobilize his research and communicate his knowledge and findings to basic scientists, clinical scientists and treating physicians as well as to patients. Dr. Rose is currently president elect for International Society for Hepatic Encephalopathy and Nitrogen Metabolism.